Cynosure to Merge With Lutronic, becoming Cynosure Lutronic, Inc.

Hahn & Company announces Cynosure and Lutronic merger to revolutionise patient care and redefine the industry. 

Hahn & Company, a leading private equity investment firm, announces a landmark move in the aesthetics industry with the strategic merger of two pioneering companies, Cynosure and Lutronic, becoming Cynosure Lutronic, Inc., this merged entity is poised to set new standards of excellence and revolutionize patient care worldwide. 

"Uniting Cynosure and Lutronic signifies a bold step towards reshaping the landscape of medical aesthetics. This merger embodies our collective dedication to pushing boundaries and ensuring excellence in customer experience," said Nadav Tomer, who will be CEO of the newly merged entity. 

Cynosure, the world’s leading aesthetic energy device manufacturer, renowned for its cutting-edge technologies, joins forces with Lutronic, which has led the medical aesthetic industry, forging a legacy as the leading authority in laser technology for two decades. Leveraging their combined expertise, resources, and technological prowess, the merged entity is poised to set new standards of excellence and revolutionize patient care worldwide. With a shared vision to enhance patient outcomes and expand accessibility to advanced aesthetic solutions, the merger between Cynosure and Lutronic is set to redefine the industry’s competitive landscape.  

The merger will enable the combined entity to offer an unparalleled portfolio of aesthetic solutions, encompassing laser systems, energy-based devices, and advanced skincare technologies. By uniting their R&D capabilities, the companies aim to introduce innovative treatments that address a diverse range of patient needs, spanning cosmetic dermatology, plastic surgery, and medical aesthetics. 

About Cynosure Lutronic, Inc 

With over 30 years of combined innovation and action as the global leader in energy-based devices and superior medical aesthetic treatments. Cynosure Lutronic enables dermatologists, plastic surgeons, medical spas, and other healthcare practitioners to deliver non-invasive and minimally invasive procedures to their patients. Committed to research and development at the forefront of aesthetic technology, Cynosure Lutronic holds the largest market leading portfolio of products in skin resurfacing and revitalization, hair removal, vascular lesion treatment, skin toning, and body contouring. Cynosure Lutronic sells its products globally through a direct sales force in the United States, Canada, France, Morocco, Germany, Spain, the United Kingdom, Australia, China, Japan, and Korea, and through international distributors in approximately 130 other countries. 

About Hahn & Co. 

Hahn & Co. is Korea's largest private equity investment firm operating in Korea. Companies controlled by Hahn & Co. generate revenues in excess of KRW20 trillion (US$15 billion) with assets of KRW34 trillion (US$27 billion) with over 30,000 employees worldwide (www.hcompany.com).